(Q38328379)

English

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice (English)

1 reference

Europe PubMed Central

2 September 2017

steatohepatitis

0 references

Elizabeth M. Brunt

5

object named as

Elizabeth M Brunt

1 reference

Europe PubMed Central

2 September 2017

author name string

James L Trevaskis

1

1 reference

Europe PubMed Central

2 September 2017

Peter S Griffin

2

1 reference

Europe PubMed Central

2 September 2017

Carrie Wittmer

3

1 reference

Europe PubMed Central

2 September 2017

Brent A Neuschwander-Tetri

4

1 reference

Europe PubMed Central

2 September 2017

Carrie S Dolman

6

1 reference

Europe PubMed Central

2 September 2017

Mary R Erickson

7

1 reference

Europe PubMed Central

2 September 2017

James Napora

8

1 reference

Europe PubMed Central

2 September 2017

David G Parkes

9

1 reference

Europe PubMed Central

2 September 2017

Jonathan D Roth

10

1 reference

Europe PubMed Central

2 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 January 2012

1 reference

Europe PubMed Central

2 September 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 reference

Europe PubMed Central

2 September 2017

302

1 reference

Europe PubMed Central

2 September 2017

8

1 reference

Europe PubMed Central

2 September 2017

G762-72

1 reference

Europe PubMed Central

2 September 2017

Epidemiology and natural history of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Biological activity of AC3174, a peptide analog of exendin-4.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Animal models of NASH: getting both pathology and metabolic context right

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

The epidemiology of nonalcoholic fatty liver disease: a global perspective

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effect of weight reduction on hepatic abnormalities in overweight patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Effects of weight loss on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Incretin mimetics as a novel therapeutic option for hepatic steatosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00476.2011

21 January 2018

Identifiers

10.1152/AJPGI.00476.2011

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38328379&oldid=1753698118"